Prevention & Lipids
Blood pressure targets and treatment strategies
Emerging evidence with 100 primary claims
Specific, answerable questions in this area — each with its own synthesized evidence and consensus. Open one to see the forest plot, source trials, and how the consensus has changed over time.
Does captopril vs atenolol improve outcomes in Diabetes Mellitus, Type 2?
Low Certainty+ Favors benefitcaptopril vs atenolol · Stroke Hospitalization
Does dexmedetomidine vs placebo improve Acute Kidney Injury in Hypertensive disease?
Low Certainty+ Favors benefitdexmedetomidine vs placebo · Acute Kidney Injury
Does captopril vs atenolol improve Stroke Hospitalization in Diabetes Mellitus, Type 2?
Low Certainty+ Favors benefitcaptopril vs atenolol · Stroke Hospitalization
Does angiotensin-converting enzyme inhibitors vs angiotensin ii receptor blockers improve Stroke Hospitalization in Hypertensive disease?
Low Certainty− Favors harmangiotensin-converting enzyme inhibitors vs angiotensin ii receptor blockers · Stroke Hospitalization
Does losartan vs placebo improve outcomes in Hypertensive disease?
Low Certainty− Favors harmlosartan vs placebo · Left Ventricular Ejection Fraction
Does antihypertensive therapy vs placebo improve outcomes in Hypertensive disease?
Low Certainty− Favors harmantihypertensive therapy vs placebo · Cardiac Output
Hypertension management (also known as HTN, high blood pressure, BP management). Blood pressure targets and treatment strategies
Synapse tracks 6 specific clinical questions in Hypertension management, each synthesized independently from its own trial evidence. They include: "Does captopril vs atenolol improve outcomes in Diabetes Mellitus, Type 2?"; "Does dexmedetomidine vs placebo improve Acute Kidney Injury in Hypertensive disease?"; "Does captopril vs atenolol improve Stroke Hospitalization in Diabetes Mellitus, Type 2?"; "Does angiotensin-converting enzyme inhibitors vs angiotensin ii receptor blockers improve Stroke Hospitalization in Hypertensive disease?"; "Does losartan vs placebo improve outcomes in Hypertensive disease?".
As of 2026-06-25, the scientific consensus on Hypertension management is emerging. Emerging evidence with 100 primary claims Based on 100 analyzed claims across Synapse's enriched corpus, the evidence shows.
This evidence brief synthesizes Synapse's enriched cardiology corpus; cite as synapsesocial.com/topics/69b0a314b42209bc31dca348.
Deterministic synthesis from Synapse's enriched corpus — 134 words. No AI-generated novel content; every figure is sourced from the underlying paper, guideline, or trial record linked on this page.
Explore every Hypertension management paper on Synapse with AI-enriched clinical evidence, PICO analysis, and methodology classification.
Search Hypertension management papersPowered by Synapse — AI-enriched analysis of 600,000+ peer-reviewed papers